Pre-reinstatement Disclosure
Filed with ASX · · 17 pages · English
Epsilon Healthcare Limited (“EPN” or the “Company”) provides the following information to the Australian Securities Exchange (“ASX”) for release. This pre-reinstatement disclosure has been prepared to ensure the market is fully informed of all material developments concerning the Company during the period in which EPN’s securities have been suspended from quotation, and to confirm that all necessa
Epsilon Healthcare Limited on 6ix
Earlier from Epsilon Healthcare
- Strengthening working capital position
- Half Yearly Report and Accounts
- Long Term Suspended Entities
- Suspension from Official Quotation - Annual Listing Fees
- Strategic $6.7m Sale and Leaseback of Southport Property
Later from Epsilon Healthcare
- Reinstatement to Quotation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Epsilon Pharma signs manufacturing agreement with Puro NZ
- Preliminary Final Report
Follow Epsilon Healthcare into a list and get an email when it puts out news.
Follow Epsilon Healthcare